// App-Quantinova.ai

11024 : IDH mutations to predict shorter survival in chondrosarcoma.

Researchers

Presenter

  • Iwona Lugowska

Principal Investigators

  • Michal Mikula

  • Pawel Teterycz

  • Maria Kulecka

  • Anna Kluska

  • Magdalena Piatkowska

  • Aneta Balabas

  • Michal Wagrodzki

  • Andrzej Pienkowski

  • Piotr Rutkowski

  • Jerzy Ostrowski

Medical Centers

  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Warsaw, Poland

  • Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  • Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Warsaw, Poland

  • Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Center for Postgraduate Education, Warsaw, Poland

  • Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  • Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

  • Maria Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland

  • Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chondrosarcoma

  • Solid malignancies

Biomarkers

  • Isocitrate dehydrogenase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved